An International, Phase 3, Open-label, Randomized Study of BGB-3111 Compared with Bendamustine plus Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Project: Research

StatusActive
Effective start/end date1/11/1931/10/24

Keywords

  • clinical trial
  • phase 3 study
  • treatment efficacy
  • leukemia
  • lymphoma